Article Details
Retrieved on: 2021-08-18 20:43:32
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
In a crowded heart failure market, Jardiance is competing with Novartis' Entresto, AstraZeneca's Farxiga and Bayer and Merck's Verquvo. (Fierce ...
Article found on: www.fiercepharma.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here